173 related articles for article (PubMed ID: 3048951)
1. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
Cappelli R; Nicora M; Di Perri T
Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
[TBL] [Abstract][Full Text] [Related]
3. [Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone].
Weindorf N; Schultz-Ehrenburg U
Z Hautkr; 1987 Jan; 62(1):28-38. PubMed ID: 3554800
[TBL] [Abstract][Full Text] [Related]
4. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
Boyle P; Diehm C; Robertson C
Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
[TBL] [Abstract][Full Text] [Related]
6. [Chronic venous insufficiency: an open trial of FLEBS Crema].
Consoli A
Minerva Cardioangiol; 2003 Aug; 51(4):411-6. PubMed ID: 12900723
[TBL] [Abstract][Full Text] [Related]
7. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino R; Penenory A; Buceta AM
Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
Carpentier PH; Mathieu M
J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
[TBL] [Abstract][Full Text] [Related]
9. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
Guex JJ; Avril L; Enrici E; Enriquez E; Lis C; Taïeb C
Int Angiol; 2010 Dec; 29(6):525-32. PubMed ID: 21173734
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of internally effective venous drugs].
Friederich HC; Vogelsberg H; Neiss A
Z Hautkr; 1978 Jun; 53(11):369-74. PubMed ID: 351993
[No Abstract] [Full Text] [Related]
11. [Venous constriction by local administration of ruscus extract].
Berg D
Fortschr Med; 1990 Aug; 108(24):473-6. PubMed ID: 2227746
[TBL] [Abstract][Full Text] [Related]
12. [Centella asiatica extract in venous disorders of the lower limbs. Comparative clinico-instrumental studies with a placebo].
Allegra C; Pollari G; Criscuolo A; Bonifacio M; Tabassi D
Clin Ter; 1981 Dec; 99(5):507-13. PubMed ID: 7037273
[No Abstract] [Full Text] [Related]
13. [Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency].
Bisler H; Pfeifer R; Klüken N; Pauschinger P
Dtsch Med Wochenschr; 1986 Aug; 111(35):1321-9. PubMed ID: 3527643
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs].
De Caprio M; Vinci L; Giumetti D; Colitta G
Clin Ter; 1982 Jun; 101(5):497-508. PubMed ID: 6897029
[No Abstract] [Full Text] [Related]
15. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].
Honorato Pérez J; Arcas Meca R
Rev Med Univ Navarra; 1990; 34(2):77-9. PubMed ID: 2130425
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study.
Boccalon H; Causse C; Yubero L
Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028
[TBL] [Abstract][Full Text] [Related]
17. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P
Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
Laurent R; Gilly R; Frileux C
Int Angiol; 1988; 7(2 Suppl):39-43. PubMed ID: 3053942
[TBL] [Abstract][Full Text] [Related]
19. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
20. [Supplementary drug therapy in the treatment of venous insufficiency. Results of a double-blind study].
Coninx S
Fortschr Med; 1974 Jun; 92(18):792-4. PubMed ID: 4605974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
